Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.Claudia Wahl, Roland M. Schmid|Journal of Clinical Investigation|1998Cited by 737
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Lorenza Rimassa et al.|The Lancet Oncology|2012Cited by 550
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal CancerMatthias Ebert, Roland M. Schmid, Jan Stöhlmacher-Williams et al.|New England Journal of Medicine|2012Cited by 184
Impaired Autophagy Induces Chronic Atrophic Pancreatitis in Mice via Sex- and Nutrition-Dependent ProcessesKalliope N. Diakopoulos, Hana Algül, Marina Lesina et al.|Gastroenterology|2014Cited by 180
Caveats of caveolin-1 in cancer progressionElke Burgermeister, Matthias Ebert, Mordechai Liscovitch et al.|Cancer Letters|2008Cited by 140